Core Insights - Lemonade, Inc. is a technology-driven insurance company utilizing artificial intelligence to enhance its services and differentiate itself from traditional insurers [1] - The company has seen a significant stock price increase of 214% over the past year, despite 42% of analysts recommending to sell [3] - Morgan Stanley has raised its price target for Lemonade from $45 to $49 while maintaining an "Underweight" rating, indicating a cautious outlook [2] Financial Performance - Lemonade's market capitalization is approximately $5.77 billion, with a trading volume of 2,800,647 shares [4] - The company is approaching profitability on an adjusted EBITDA basis, showing consistent high growth and improving financial performance [4] - The stock is currently trading at around $78.87, with a recent increase of $3.85, or 5.13% [3] Market Activity - During a recent trading day, Lemonade's stock fluctuated between a low of $75.52 and a high of $80.12 [3] - The third quarter was particularly strong for the company, contributing to positive market reception [4]
Lemonade, Inc. (NYSE:LMND) Continues to Impress Despite "Underweight" Rating